Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2015 2
2017 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Oral versus intravenous fluoropyrimidines for colorectal cancer.
Chionh F, Lau D, Yeung Y, Price T, Tebbutt N. Chionh F, et al. Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD008398. doi: 10.1002/14651858.CD008398.pub2. Cochrane Database Syst Rev. 2017. PMID: 28752564 Free PMC article. Review.
Grade 3 adverse events (AEs): Participants treated with oral fluoropyrimidines experienced less grade 3 neutropenia/granulocytopenia (odds ratio (OR) 0.14, 95% CI 0.11 to 0.16; seven studies, 8087 participants; moderate-quality evidence), stomatitis (OR 0.21, 95% CI 0.14 t …
Grade 3 adverse events (AEs): Participants treated with oral fluoropyrimidines experienced less grade 3 neutropenia/granulocytopenia …
Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis.
Lanini S, Molloy AC, Fine PE, Prentice AG, Ippolito G, Kibbler CC. Lanini S, et al. BMC Med. 2011 Apr 12;9:36. doi: 10.1186/1741-7015-9-36. BMC Med. 2011. PMID: 21481281 Free PMC article. Review.
Meta-analysis was performed on overall incidence of severe infection, risk of dying as the consequence of infection, risk of febrile neutropenia, risk of severe leucopenia, risk of severe granulocytopenia and overall response assuming a fixed effect model. Heterogeneity wa …
Meta-analysis was performed on overall incidence of severe infection, risk of dying as the consequence of infection, risk of febrile neutrop …
Severe and fatal adverse events risk associated with rituximab addition to B-cell non-Hodgkin's lymphoma (B-NHL) chemotherapy: a meta-analysis.
Hua Q, Zhu Y, Liu H. Hua Q, et al. J Chemother. 2015;27(6):365-70. doi: 10.1179/1973947815Y.0000000025. Epub 2015 Apr 15. J Chemother. 2015. PMID: 25872413 Review.
Summary RR obtained showed no statistically significant rituximab-associated increased risk in 13 severe adverse events (SAEs) (infection, fever, anaemia, thrombocytopaenia, granulocytopenia, liver toxicity, cardiac toxicity, neurologic toxicity, lung toxicity, mucositis, …
Summary RR obtained showed no statistically significant rituximab-associated increased risk in 13 severe adverse events (SAEs) (infection, f …
A meta-analysis of lentinan injection combined with chemotherapy in the treatment of nonsmall cell lung cancer.
Yin X, Ying J, Li L, Zhang H, Wang H. Yin X, et al. Indian J Cancer. 2015 Nov;52 Suppl 1:e29-31. doi: 10.4103/0019-509X.168953. Indian J Cancer. 2015. PMID: 26548936 Free article.
The chemotherapy-related toxicity of III/IV gastrointestinal reaction (RR = 0.54, 95% CI: 0.43-0.68) and III/IV granulocytopenia (RR = 0.65, 95% CI: 0.51-0.70) were significant decreased in the combined group. ...
The chemotherapy-related toxicity of III/IV gastrointestinal reaction (RR = 0.54, 95% CI: 0.43-0.68) and III/IV granulocytopenia (RR …
Cytomegalovirus retinitis in children and adolescents with acute leukemia following allogeneic hematopoietic stem cell transplantation.
Zöllner SK, Herbrüggen H, Kolve H, Mihailovic N, Schubert F, Reicherts C, Rössig C, Groll AH. Zöllner SK, et al. Transpl Infect Dis. 2019 Oct;21(5):e13089. doi: 10.1111/tid.13089. Epub 2019 Aug 13. Transpl Infect Dis. 2019. PMID: 30972869
Foscarnet is used in case of resistance to ganciclovir or drug-induced granulocytopenia. Overall, CMVR after HSCT in pediatric leukemic patients is rare, but a potentially higher vulnerability of this population for involvement of the eye warrants a standardized ophthalmol …
Foscarnet is used in case of resistance to ganciclovir or drug-induced granulocytopenia. Overall, CMVR after HSCT in pediatric leukem …